CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-07 | ADAMS R MARK Chief Operating Officer | Sale | −825 | $9.53 | $8K | 122,068 |
| 2022-06-01 | PETERSON TYCHO Chief Financial Officer | Grant or award | +374,688 | 374,688 | ||
| 2022-06-01 | PETERSON TYCHO Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +597,157 | 597,157 | ||
| 2022-04-07 | ADAMS R MARK Chief Operating Officer | Sale | −831 | $13.17 | $11K | 122,893 |
| 2022-03-09 | ROBINS CHAD M CEO and Chairman | Option exercise | −14,815 | $6.32 | $94K | 1,930,969 |
| 2022-03-09 | ROBINS CHAD M CEO and Chairman | Sale | −14,815 | $12.46 | $185K | 1,916,154 |
| 2022-03-09 | ROBINS CHAD M CEO and Chairman | Option exercise · Stock Option (Right to Buy) | −14,815 | 755,555 | ||
| 2022-03-08 | Taylor Stacy L SVP and General Counsel | Sale | −2,387 | $11.44 | $27K | 72,859 |
| 2022-03-08 | BALDO LANCE Chief Medical Officer | Sale | −3,350 | $11.43 | $38K | 17,171 |
| 2022-03-08 | LO FRANCIS Chief People Officer | Sale | −3,582 | $11.44 | $41K | 89,588 |
| 2022-03-08 | ROBINS CHAD M CEO and Chairman | Option exercise | −14,815 | $6.32 | $94K | 1,930,969 |
| 2022-03-08 | ROBINS CHAD M CEO and Chairman | Sale | −14,815 | $11.38 | $169K | 1,916,154 |
| 2022-03-08 | ROBINS CHAD M CEO and Chairman | Option exercise · Stock Option (Right to Buy) | −14,815 | 770,370 | ||
| 2022-03-07 | ROBINS CHAD M CEO and Chairman | Option exercise | +14,815 | $6.32 | $94K | 1,930,969 |
| 2022-03-07 | ROBINS CHAD M CEO and Chairman | Sale | −500 | $12.22 | $6K | 1,930,469 |
| 2022-03-07 | ROBINS CHAD M CEO and Chairman | Sale | −14,315 | $11.53 | $165K | 1,916,154 |
| 2022-03-07 | ROBINS CHAD M CEO and Chairman | Option exercise · Stock Option (Right to Buy) | −14,815 | 785,185 | ||
| 2022-03-07 | BALDO LANCE Chief Medical Officer | Sale | −2,373 | $12.01 | $28K | 20,521 |
| 2022-03-07 | RUBINSTEIN JULIE President | Sale | −4,613 | $12.01 | $55K | 226,513 |
| 2022-03-07 | BENZENO SHARON Chief Business Development Off | Sale | −2,670 | $12.01 | $32K | 102,596 |
Page 35 of 120 · 2,386 trades